European COVID-19 Project An ‘Unprecedented’ Exercise In Cooperation
37 Public & Private Partners To Research Potential New Treatments
Repurposed drugs, new compounds and neutralizing antibodies are among the targets of a new collaborative venture supported by Europe’s Innovative Medicines Initiative.
You may also be interested in...
A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.
With elections taking place across the UK on 6 May, the Scottish National Party says it plans to take steps to ensure sustainable medicine supply chains and build up the manufacturing of generics and “specials” within the National Health Service in Scotland.
Coronavirus Notebook: EMA Begins Rolling Review of Sinovac Vaccine, Looks At Comirnaty In 12-15-Year Age Group
Moderna and Sweden are donating vaccines to the COVAX Facility, and an African trial is investigating a combination of nitazoxanide and ciclesonide in people with mild-to-moderate COVID-19.